Literature DB >> 2671038

Evolution of the levels of soluble interleukin-2 receptors during Plasmodium falciparum and P. vivax malaria.

P Deloron1, J P Lepers, P Coulanges.   

Abstract

Increased levels of soluble interleukin-2 receptors (IL-2R) in serum were observed in both Plasmodium falciparum- and P. vivax-infected individuals compared with nonparasitemic subjects. Clinical symptoms of P. falciparum malaria were associated with higher levels of soluble IL-2R. Temporal evolution in serum of IL-2R during the course of a malaria attack mimicked the kinetics of soluble IL-2R under experimental conditions.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2671038      PMCID： PMC267692          DOI： 10.1128/jcm.27.8.1887-1889.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Increased levels of released interleukin-2 receptors in Plasmodium falciparum malaria.

Authors:  P Nguyen-Dinh; A E Greenberg
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

Review 2.  The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses.

Authors:  W C Greene; W J Leonard; J M Depper; D L Nelson; T A Waldmann
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

3.  Reappearance of falciparum malaria in central highland plateaux of Madagascar.

Authors:  J P Lepers; P Deloron; D Fontenille; P Coulanges
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

4.  Plasma interleukin 2 receptor levels in renal allograft recipients.

Authors:  R B Colvin; T C Fuller; L MacKeen; P C Kung; S H Ip; A B Cosimi
Journal:  Clin Immunol Immunopathol       Date:  1987-05

5.  Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.

Authors:  G E Grau; L F Fajardo; P F Piguet; B Allet; P H Lambert; P Vassalli
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

6.  Interleukin 2 receptor in patients with localized and systemic parasitic diseases.

Authors:  O Josimovic-Alasevic; H Feldmeier; K Zwingenberger; G Harms; H Hahn; M Shrisuphanunt; T Diamantstein
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

Review 7.  Interleukin-2: inception, impact, and implications.

Authors:  K A Smith
Journal:  Science       Date:  1988-05-27       Impact factor: 47.728

8.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.

Authors:  G Pizzolo; M Chilosi; F Vinante; F Dazzi; M Lestani; G Perona; F Benedetti; G Todeschini; C Vincenzi; L Trentin
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

10.  Transient expression of interleukin 2 receptors. Consequences for T cell growth.

Authors:  D A Cantrell; K A Smith
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307
  10 in total
  13 in total

1.  Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.

Authors:  R Harpaz; R Edelman; S S Wasserman; M M Levine; J R Davis; M B Sztein
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Longitudinal survey in an endemic region of plasma soluble interleukin-2 receptor and antibody levels in Plasmodium falciparum malaria.

Authors:  B F Chumpitazi; F Peyron; J Simon; C Boudin; I Sheick-Zakiuddin; S Picot; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  Modulation of the cellular immune response during Plasmodium falciparum infections in sickle cell trait individuals.

Authors:  Y A Abu-Zeid; T G Theander; N H Abdulhadi; L Hviid; B O Saeed; S Jepsen; J B Jensen; R A Bayoumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

4.  Plasmodium falciparum induces apoptosis in human mononuclear cells.

Authors:  A Toure-Balde; J L Sarthou; G Aribot; P Michel; J F Trape; C Rogier; C Roussilhon
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

5.  Immunological markers of childhood fevers in an area of intense and perennial malaria transmission.

Authors:  N Hurt; M Thein; T Smith; G Bordmann; H Gallati; N Drees; M Tanner; N Weiss
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

6.  Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria.

Authors:  P H Jakobsen; S Morris-Jones; T G Theander; L Hviid; M B Hansen; K Bendtzen; R G Ridley; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

7.  Malaria associated apoptosis is not significantly correlated with either parasitemia or the number of previous malaria attacks.

Authors:  Evelyn K P Riccio; Ivan Neves Júnior; Lilian R Pratt Riccio; Maria das Graças Alecrim; Suzana Corte-Real; Mariza Morgado; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Parasitol Res       Date:  2003-01-28       Impact factor: 2.289

8.  Circulating stable antigens at higher levels down-regulate antibody responses to Plasmodium falciparum.

Authors:  B Chumpitazi; J P Lepers; M Rason; A Meunier; C Boudin; P Ambroise-Thomas
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

9.  Levels of cytokines in plasma during Plasmodium falciparum malaria attacks.

Authors:  P Ringwald; F Peyron; J P Vuillez; J E Touze; J Le Bras; P Deloron
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

10.  Soluble plasma IL-2 receptors and malaria.

Authors:  E M Riley; P Rowe; S J Allen; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.